{"disease":{"id":"weight-loss","name":"Weight loss","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":8,"pipeline_drug_count":0,"trial_count":19},"drugs":{"marketed":[{"drug_id":"semaglutide","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ozempic","generic_name":"semaglutide","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"GLP-1 receptor","drug_class":"GLP-1 Receptor Agonist [EPC]","quality_score":90,"revenue":"27400","mechanism":"Semaglutide, a GLP-1 analogue, lowers blood glucose by stimulating insulin and inhibiting glucagon secretion in a glucose-dependent manner, and delays gastric emptying."},{"drug_id":"liraglutide","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Victoza","generic_name":"liraglutide","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"GLP-1 Receptor Agonist [EPC]","quality_score":35,"revenue":"3200","mechanism":null},{"drug_id":"histidine","indication_name":"Prevent Nitrogen and Weight Loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Histidine","generic_name":"HISTIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Large neutral amino acids transporter small subunit 1","drug_class":"Amino Acid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dronabinol","indication_name":"Anorexia associated with weight loss in AIDS","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Marinol","generic_name":"DRONABINOL","company_name":"Wellhouse Pharma","drug_phase":"marketed","molecular_target":"Cannabinoid receptors","drug_class":"Cannabinoid [EPC]","quality_score":80,"revenue":null,"mechanism":"Dronabinol acts on cannabinoid receptors in the CNS, potentially through central sympathomimetic activity."},{"drug_id":"pentorex","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenpentermine","generic_name":"PENTOREX","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"pentorex","quality_score":null,"revenue":null,"mechanism":"Phenpentermine works by increasing the levels of certain neurotransmitters in the brain that help regulate appetite and metabolism."},{"drug_id":"lopid","indication_name":"Reducing risk of developing coronary heart disease in Type IIb patients without history or symptoms of existing coronary heart disease with low HDL-cholesterol, elevated LDL-cholesterol, and elevated triglycerides unresponsive to weight loss, diet, exercise, and other pharmacologic agents","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopid","generic_name":"Gemfibrozil","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"PPAR-alpha (Peroxisome Proliferator-Activated Receptor Alpha)","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"liraglutid","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Liraglutid","company_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"saxenda","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Saxenda","company_name":"Seoul National University Hospital","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"victoza","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Victoza","company_name":"Hanmi Pharmaceutical Company Limited","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"aminorex","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Apiquel","generic_name":"AMINOREX","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"aminorex","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"alanine","indication_name":"Prevent Nitrogen and Weight Loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Alanine","generic_name":"ALANINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Amino Acid [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"rybelsus","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rybelsus","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"glutamic-acid","indication_name":"Prevent Nitrogen and Weight Loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glutamate","generic_name":"GLUTAMIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Glutamate dehydrogenase 1, mitochondrial, Glutamate dehydrogenase 2, mitochondrial, Metabotropic glutamate receptor 6","drug_class":"Amino Acid [EPC]","quality_score":50,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":13,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06275061","title":"Chinese Obesity and MEtabolic Surgery Database (COMES Database)","phase":"","overall_status":"RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Jinan University Guangzhou","has_results":false},{"nct_id":"NCT04907396","title":"International Weight Control Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Tufts University","has_results":false},{"nct_id":"NCT05121844","title":"Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":31187,"lead_sponsor_name":"Signos Inc","has_results":false},{"nct_id":"NCT05874635","title":"Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Signos Inc","has_results":false},{"nct_id":"NCT07059104","title":"Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT04494048","title":"Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry","phase":"","overall_status":"RECRUITING","enrollment_count":9999,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT06226194","title":"Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":6966,"lead_sponsor_name":"Institut de Recerca Biomèdica de Lleida","has_results":false},{"nct_id":"NCT06024161","title":"Weight Change and the Risk of Chronic Pain Following Hip and Knee Arthroplasties","phase":"","overall_status":"UNKNOWN","enrollment_count":6400,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT05725967","title":"Endoscopic Metabolic and Bariatric Therapies","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Christopher C. Thompson, MD, MSc","has_results":false},{"nct_id":"NCT07104500","title":"VK2735 for Weight Management Phase 3","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4500,"lead_sponsor_name":"Viking Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04224727","title":"The Impact of Group Commitment Contracts on Smoking Cessation and Weight Loss","phase":"NA","overall_status":"SUSPENDED","enrollment_count":3600,"lead_sponsor_name":"National Bureau of Economic Research, Inc.","has_results":false},{"nct_id":"NCT04630977","title":"Long-term Intervention Effects of a Personalized, Home-based Exercise Program and Nutritional Advice, Along With the Inclusion of a Pre-workout Multi-ingredient Supplement on the Body Composition, Functional Capacity and Quality of Life of Middle-aged and Older Adults (40-70 Years)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"University of Greenwich","has_results":false},{"nct_id":"NCT03741010","title":"Belviq Tablet® Post Marketing Surveillance Protocol","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"IlDong Pharmaceutical Co Ltd","has_results":false},{"nct_id":"NCT05859867","title":"Bimbingamba Zerosix Third Phase: Studying Communities","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Azienda Ospedaliero Universitaria Maggiore della Carita","has_results":false},{"nct_id":"NCT06963528","title":"Gestational Diabetes Monitoring and Management","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1800,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04516642","title":"Swiss Frailty Network and Repository","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03675464","title":"Study of Human Adipose Tissue (LOSHAT)","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT02841527","title":"Gastric Bypass, Gastric Band or Sleeve Gastrectomy to Treat Obesity","phase":"NA","overall_status":"COMPLETED","enrollment_count":1351,"lead_sponsor_name":"University of Bristol","has_results":false},{"nct_id":"NCT07144800","title":"Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)","phase":"NA","overall_status":"RECRUITING","enrollment_count":1319,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04364282","title":"Stay In Treatment for Pediatric Weight Management","phase":"NA","overall_status":"COMPLETED","enrollment_count":1216,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT07104383","title":"VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Viking Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05481697","title":"Unintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking Combin","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT06157606","title":"Prediction Model for Inadequate Weight Loss After Sleeve Gastrectomy","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT03188094","title":"Integrated Community-Clinical Linkage Model to Promote Weight Loss Among South Asians With Pre-Diabetes","phase":"NA","overall_status":"COMPLETED","enrollment_count":974,"lead_sponsor_name":"NYU Langone Health","has_results":true},{"nct_id":"NCT06455878","title":"Mobile Applet for Weight Management in Obese Heart Failure Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":830,"lead_sponsor_name":"Heart Health Research Center","has_results":false},{"nct_id":"NCT04575987","title":"Long Term Effect of Bariatric Surgery on Pelvic Floor Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":709,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT05790174","title":"Weight-loss Treatment Program in Children and Adolescents","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":700,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT02634268","title":"INtervention Study In overweiGHT Patients With COPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Seattle Institute for Biomedical and Clinical Research","has_results":true},{"nct_id":"NCT03305172","title":"Structuring Financial Incentives to Increase Physical Activity","phase":"NA","overall_status":"COMPLETED","enrollment_count":620,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT07387393","title":"To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Hawaii","has_results":false},{"nct_id":"NCT04797169","title":"Noom Health for Weight Management","phase":"NA","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":true},{"nct_id":"NCT03430115","title":"Health Outcomes After Participating in Exercise (HOPE)","phase":"","overall_status":"COMPLETED","enrollment_count":588,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT06785064","title":"Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance","phase":"NA","overall_status":"RECRUITING","enrollment_count":544,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT03254940","title":"Charge: A Text Messaging-based Weight Loss Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":534,"lead_sponsor_name":"Duke University","has_results":true},{"nct_id":"NCT07239167","title":"A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT05291741","title":"Use of Very Low Calorie Diet Preoperatively to Bariatric Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT03342274","title":"Adapting the Diabetes Prevention Program for a Developing World Context","phase":"NA","overall_status":"COMPLETED","enrollment_count":494,"lead_sponsor_name":"Children's Mercy Hospital Kansas City","has_results":false},{"nct_id":"NCT05621109","title":"PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Copenhagen","phase":"NA","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Christian Mølgaard","has_results":false},{"nct_id":"NCT05136339","title":"Healthy Immigrant Community: Mobilizing the Power of Social Networks","phase":"NA","overall_status":"COMPLETED","enrollment_count":475,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT06710587","title":"Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication?","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":470,"lead_sponsor_name":"Menwell Limited","has_results":false},{"nct_id":"NCT03057808","title":"Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight)","phase":"NA","overall_status":"COMPLETED","enrollment_count":430,"lead_sponsor_name":"University of Tennessee","has_results":true},{"nct_id":"NCT06666842","title":"Longitudinal Effects of a Commercial Digital Weight Management Program on Weight Loss","phase":"NA","overall_status":"COMPLETED","enrollment_count":412,"lead_sponsor_name":"Noom Inc.","has_results":false},{"nct_id":"NCT02997943","title":"SMART Weight Loss Management","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05108675","title":"Microbiome and Malnutrition in Pregnancy (MMiP)","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT06508840","title":"The Clear Conversations Project","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Sheffield","has_results":false},{"nct_id":"NCT06584578","title":"Exercise Nutrition and Body Composition","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Karabuk University","has_results":false},{"nct_id":"NCT03036800","title":"Saxenda in Obesity Services (STRIVE Study)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":392,"lead_sponsor_name":"University of Leicester","has_results":true},{"nct_id":"NCT06205563","title":"The Therapeutic Effect of Different Exercise Intensities on Weight Loss in Obese Children","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":388,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06214221","title":"Using Signos mHealth Platform in Adults for Weight Management","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":380,"lead_sponsor_name":"Signos Inc","has_results":false},{"nct_id":"NCT03571893","title":"Study of an International Commercial Program on Weight Loss and Health Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":373,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}